Australia · Delayed Price · Currency is AUD Tissue Repair Statistics
Total Valuation
Tissue Repair has a market cap or net worth of AUD 4.96 million. The enterprise value is 187,367.
| Market Cap | 4.96M |
| Enterprise Value | 187,367 |
Important Dates
The last earnings date was Thursday, September 3, 2026.
| Earnings Date | Sep 3, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Tissue Repair has 60.46 million shares outstanding.
| Current Share Class | 60.46M |
| Shares Outstanding | 60.46M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | -0.21% |
| Owned by Insiders (%) | 12.12% |
| Owned by Institutions (%) | 10.29% |
| Float | 34.36M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.66 |
| PB Ratio | 0.57 |
| P/TBV Ratio | 0.57 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.06 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.36
| Current Ratio | 6.36 |
| Quick Ratio | 5.74 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -47.27% and return on invested capital (ROIC) is -30.55%.
| Return on Equity (ROE) | -47.27% |
| Return on Assets (ROA) | -27.82% |
| Return on Invested Capital (ROIC) | -30.55% |
| Return on Capital Employed (ROCE) | -63.13% |
| Weighted Average Cost of Capital (WACC) | 5.43% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.24 |
| Inventory Turnover | 0.61 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -69.63% in the last 52 weeks. The beta is 0.22, so Tissue Repair's price volatility has been lower than the market average.
| Beta (5Y) | 0.22 |
| 52-Week Price Change | -69.63% |
| 50-Day Moving Average | 0.09 |
| 200-Day Moving Average | 0.21 |
| Relative Strength Index (RSI) | 42.46 |
| Average Volume (20 Days) | 138,480 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Tissue Repair had revenue of AUD 2.99 million and -5.36 million in losses. Loss per share was -0.09.
| Revenue | 2.99M |
| Gross Profit | 2.77M |
| Operating Income | -5.54M |
| Pretax Income | -5.36M |
| Net Income | -5.36M |
| EBITDA | -5.32M |
| EBIT | -5.54M |
| Loss Per Share | -0.09 |
Balance Sheet
The company has 4.77 million in cash and no debt, with a net cash position of 4.77 million or 0.08 per share.
| Cash & Cash Equivalents | 4.77M |
| Total Debt | n/a |
| Net Cash | 4.77M |
| Net Cash Per Share | 0.08 |
| Equity (Book Value) | 8.77M |
| Book Value Per Share | 0.15 |
| Working Capital | 8.37M |
Cash Flow
In the last 12 months, operating cash flow was -7.50 million and capital expenditures -43,645, giving a free cash flow of -7.55 million.
| Operating Cash Flow | -7.50M |
| Capital Expenditures | -43,645 |
| Depreciation & Amortization | 222,579 |
| Net Borrowing | n/a |
| Free Cash Flow | -7.55M |
| FCF Per Share | -0.12 |
Margins
Gross margin is 92.50%, with operating and profit margins of -185.40% and -179.28%.
| Gross Margin | 92.50% |
| Operating Margin | -185.40% |
| Pretax Margin | -179.28% |
| Profit Margin | -179.28% |
| EBITDA Margin | -177.95% |
| EBIT Margin | -185.40% |
| FCF Margin | n/a |
Dividends & Yields
Tissue Repair does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | n/a |
| Shareholder Yield | n/a |
| Earnings Yield | -108.15% |
| FCF Yield | -152.23% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Tissue Repair has an Altman Z-Score of 1.26 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.26 |
| Piotroski F-Score | 1 |